Absci (ABSI) Common Equity (2020 - 2026)
Absci's (ABSI) quarterly Common Equity came in at $172.0 million in Q1 2026, down 13.49% year-on-year from $198.8 million in Q1 2025, and down 9.23% quarter-over-quarter from $189.4 million in Q4 2025.
Absci (ABSI) Common Equity (2020 - 2026) Analysis & Trends
Absci has disclosed Common Equity across 7 years of filings, most recently posting $172.0 million for Q1 2026.
- Common Equity for Q1 2026 came in at $172.0 million, down 13.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $172.0 million (down 13.49% YoY), and the FY2025 annual result was $189.4 million, up 5.76% from the prior year.
- Common Equity came in at $172.0 million for Q1 2026 at Absci, down from $189.4 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $340.5 million in Q1 2022 to a low of $172.0 million in Q1 2026.
- The 5-year median for Common Equity is $210.3 million (2025), against an average of $226.6 million.
- Across the five-year window, Common Equity surged 445.67% in 2022 and sank 35.8% in 2023, its largest moves.
- Absci's Common Equity stood at $274.4 million in 2022, then tumbled by 35.8% to $176.2 million in 2023, then advanced by 1.68% to $179.1 million in 2024, then climbed by 5.76% to $189.4 million in 2025, then slipped by 9.23% to $172.0 million in 2026.
- The last three Common Equity figures came in at $172.0 million (Q1 2026), $189.4 million (Q4 2025), and $210.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 171.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.97 Mn |
| Dec 31, 2025 | 189.45 Mn |
| Sep 30, 2025 | 210.34 Mn |
| Jun 30, 2025 | 173.37 Mn |
| Mar 31, 2025 | 198.80 Mn |
| Dec 31, 2024 | 179.13 Mn |
| Sep 30, 2024 | 201.34 Mn |
| Jun 30, 2024 | 221.49 Mn |
| Mar 31, 2024 | 240.11 Mn |
| Dec 31, 2023 | 176.18 Mn |
| Sep 30, 2023 | 196.42 Mn |
| Jun 30, 2023 | 215.40 Mn |
| Mar 31, 2023 | 253.97 Mn |
| Dec 31, 2022 | 274.41 Mn |
| Sep 30, 2022 | 292.94 Mn |
| Jun 30, 2022 | 316.19 Mn |
| Mar 31, 2022 | 340.50 Mn |
| Dec 31, 2021 | 366.11 Mn |
| Sep 30, 2021 | 388.01 Mn |
| Jun 30, 2021 | -124.26 Mn |